Because upregulation of miR-27b reduced the tumourigenic SP fraction (Fig. 3b–d) and ENPP1 was expressed at a high level in this fraction (Supplementary Fig. 8a–c), these results indicate that ENPP1 contributes to the acquisition of resistance to anti-cancer agents. The gene discussed is ENPP1; the disease is cancer.